S. Jazayeri

546 total citations
10 papers, 443 citations indexed

About

S. Jazayeri is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Jazayeri has authored 10 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Dermatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in S. Jazayeri's work include Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). S. Jazayeri is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). S. Jazayeri collaborates with scholars based in United States, Germany and Switzerland. S. Jazayeri's co-authors include R. You, J.‐P. Lacour, C. Paul, C. Papavassilis, Stewart Adams, Petr Arenberger, John Sullivan, Matthias Augustin, Kristian Reich and P. Regnault and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

S. Jazayeri

9 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Jazayeri United States	7	412	278	98	73	53	10	443
Ting‐Shun Wang Taiwan	11	294 0.7×	178 0.6×	54 0.6×	80 1.1×	59 1.1×	18	384
P. Regnault United States	5	307 0.7×	204 0.7×	86 0.9×	54 0.7×	48 0.9×	7	327
Hany Elmaraghy United States	9	261 0.6×	315 1.1×	62 0.6×	66 0.9×	17 0.3×	30	419
Kamyar Farahi United States	7	209 0.5×	150 0.5×	28 0.3×	50 0.7×	38 0.7×	7	300
Richuan Zheng Japan	8	262 0.6×	198 0.7×	69 0.7×	61 0.8×	76 1.4×	10	351
Toshihiro Ito Japan	9	233 0.6×	130 0.5×	27 0.3×	52 0.7×	35 0.7×	15	294
Natalia Rompoti Greece	10	232 0.6×	194 0.7×	97 1.0×	47 0.6×	93 1.8×	26	326
Y. Gu United States	10	211 0.5×	489 1.8×	33 0.3×	46 0.6×	170 3.2×	15	598
Ko Nakajo Japan	7	224 0.5×	172 0.6×	59 0.6×	39 0.5×	37 0.7×	18	325
Arvin Ighani Canada	12	228 0.6×	150 0.5×	59 0.6×	34 0.5×	18 0.3×	19	290

Countries citing papers authored by S. Jazayeri

Since Specialization

Citations

This map shows the geographic impact of S. Jazayeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jazayeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jazayeri more than expected).

Fields of papers citing papers by S. Jazayeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jazayeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jazayeri. The network helps show where S. Jazayeri may publish in the future.

Co-authorship network of co-authors of S. Jazayeri

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jazayeri. A scholar is included among the top collaborators of S. Jazayeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jazayeri. S. Jazayeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

D’Cunha, Ronilda, Laura K. Ferris, Ann Eldred, et al.. (2023). 43882 Pharmacokinetics, Safety, and Efficacy of Cedirogant (ABBV-157) in Patients With Moderate-to- Severe Plaque Psoriasis. Journal of the American Academy of Dermatology. 89(3). AB206–AB206. 1 indexed citations

Mohamed, Mohamed‐Eslam F., Yuli Qian, Ronilda D’Cunha, et al.. (2023). Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and Translational Science. 17(1). e13682–e13682. 7 indexed citations

Menter, Alan, Petr Arenberger, Sigrid Balser, et al.. (2020). Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study. Expert Opinion on Biological Therapy. 21(1). 87–96. 18 indexed citations

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2020). Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study*. British Journal of Dermatology. 184(3). 425–436. 41 indexed citations

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2018). Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial. British Journal of Dermatology. 181(5). 954–966. 76 indexed citations

Lacour, J.‐P., C. Paul, S. Jazayeri, et al.. (2017). Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial. Journal of the European Academy of Dermatology and Venereology. 31(5). 847–856. 49 indexed citations

Lacour, J.‐P., A. Khemis, G. Guillet, et al.. (2016). Maintien pendant 2 ans de l’efficacité du sécukinumab administré par stylo auto-injecteur dans le psoriasis en plaques : résultats de l’étude JUNCTURE. Annales de Dermatologie et de Vénéréologie. 143(12). S192–S193.

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2016). FRI0460 Secukinumab Shows Significant Efficacy in Nail Psoriasis: Week 32 Results from The Transfigure Study. Annals of the Rheumatic Diseases. 75. 603–604. 12 indexed citations

Paul, C., J.‐P. Lacour, S. Jazayeri, et al.. (2014). Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE). Journal of the European Academy of Dermatology and Venereology. 29(6). 1082–1090. 237 indexed citations

10.

Jazayeri, S., et al.. (2004). CLINICOPATHOLOGIC CORRELATION OF THE UNSATISFACTORY PAPANICOLAOU SMEAR. ACTA MEDICA IRANICA. 42(5). 371–374. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact